Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD)

Psychopharmacology Bulletin

Volumn 32, Issue 4, 1996, Pages 677-682

  Ravizza, Luigi ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

clomipramine; obsessive compulsive disorder; refractory patients; risperidone; sertraline

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERANCE; DRUG UPTAKE; FEMALE; HUMAN; MALE; OBSESSION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADULT; CLOMIPRAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; RISPERIDONE;

EID: 0030455295     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. De Veaugh-Geiss, J; Landau, P; and Katz, R. Treatment of obsessive-compulsive disorder with clomipramine. Psychiatr.Ann. 19:97-101, 1989.